The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Peripheral Intervention Drug-Eluting Devices Market Research Report 2025

Global Peripheral Intervention Drug-Eluting Devices Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1426262

No of Pages : 87

Ask Your Query
Synopsis
Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
The global Peripheral Intervention Drug-Eluting Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Peripheral Intervention Drug-Eluting Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Intervention Drug-Eluting Devices.
Report Scope
The Peripheral Intervention Drug-Eluting Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peripheral Intervention Drug-Eluting Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Intervention Drug-Eluting Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
Abbott
The Lubrizol Corporation
Terumo Corporation
Segment by Type
Drug-Eluting Balloons
Drug-Eluting Stents
Segment by Application
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peripheral Intervention Drug-Eluting Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Peripheral Intervention Drug-Eluting Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Peripheral Intervention Drug-Eluting Devices Market Overview
1.1 Product Overview and Scope of Peripheral Intervention Drug-Eluting Devices
1.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
1.2.1 Global Peripheral Intervention Drug-Eluting Devices Market Value Comparison by Type (2024-2030)
1.2.2 Drug-Eluting Balloons
1.2.3 Drug-Eluting Stents
1.3 Peripheral Intervention Drug-Eluting Devices Segment by Application
1.3.1 Global Peripheral Intervention Drug-Eluting Devices Market Value by Application: (2024-2030)
1.3.2 Plain Old Balloon Angioplasty (POBA)
1.3.3 Percutaneous Transluminal Angioplasty (PTA)
1.4 Global Peripheral Intervention Drug-Eluting Devices Market Size Estimates and Forecasts
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Revenue 2019-2030
1.4.2 Global Peripheral Intervention Drug-Eluting Devices Sales 2019-2030
1.4.3 Global Peripheral Intervention Drug-Eluting Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Peripheral Intervention Drug-Eluting Devices Market Competition by Manufacturers
2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Peripheral Intervention Drug-Eluting Devices Average Price by Manufacturers (2019-2024)
2.4 Global Peripheral Intervention Drug-Eluting Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Product Type & Application
2.7 Peripheral Intervention Drug-Eluting Devices Market Competitive Situation and Trends
2.7.1 Peripheral Intervention Drug-Eluting Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Peripheral Intervention Drug-Eluting Devices Players Market Share by Revenue
2.7.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario by Region
3.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Peripheral Intervention Drug-Eluting Devices Global Peripheral Intervention Drug-Eluting Devices Sales by Region: 2019-2030
3.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Region: 2019-2024
3.2.2 Global Peripheral Intervention Drug-Eluting Devices Sales by Region: 2025-2030
3.3 Global Peripheral Intervention Drug-Eluting Devices Global Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2019-2030
3.3.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2019-2024
3.3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2025-2030
3.4 North America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.4.1 North America Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2030)
3.4.3 North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.5.1 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2030)
3.5.3 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.7.1 Latin America Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2030)
3.7.3 Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2030)
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2024)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2025-2030)
4.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2030)
4.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2019-2030)
4.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2019-2024)
4.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2025-2030)
4.2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2019-2030)
4.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2030)
5.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2024)
5.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2025-2030)
5.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2030)
5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2019-2030)
5.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2019-2024)
5.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2025-2030)
5.2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2019-2030)
5.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic plc
6.1.1 Medtronic plc Corporation Information
6.1.2 Medtronic plc Description and Business Overview
6.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.1.5 Medtronic plc Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Cardinal Health
6.4.1 Cardinal Health Corporation Information
6.4.2 Cardinal Health Description and Business Overview
6.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.4.5 Cardinal Health Recent Developments/Updates
6.5 B. Braun Melsungen AG
6.5.1 B. Braun Melsungen AG Corporation Information
6.5.2 B. Braun Melsungen AG Description and Business Overview
6.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.5.5 B. Braun Melsungen AG Recent Developments/Updates
6.6 Biosensors International Group Ltd.
6.6.1 Biosensors International Group Ltd. Corporation Information
6.6.2 Biosensors International Group Ltd. Description and Business Overview
6.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.6.5 Biosensors International Group Ltd. Recent Developments/Updates
6.7 C.R. Bard, Inc.
6.6.1 C.R. Bard, Inc. Corporation Information
6.6.2 C.R. Bard, Inc. Description and Business Overview
6.6.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.7.5 C.R. Bard, Inc. Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Corporation Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 The Lubrizol Corporation
6.9.1 The Lubrizol Corporation Corporation Information
6.9.2 The Lubrizol Corporation Description and Business Overview
6.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.9.5 The Lubrizol Corporation Recent Developments/Updates
6.10 Terumo Corporation
6.10.1 Terumo Corporation Corporation Information
6.10.2 Terumo Corporation Description and Business Overview
6.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.10.5 Terumo Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peripheral Intervention Drug-Eluting Devices Industry Chain Analysis
7.2 Peripheral Intervention Drug-Eluting Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peripheral Intervention Drug-Eluting Devices Production Mode & Process
7.4 Peripheral Intervention Drug-Eluting Devices Sales and Marketing
7.4.1 Peripheral Intervention Drug-Eluting Devices Sales Channels
7.4.2 Peripheral Intervention Drug-Eluting Devices Distributors
7.5 Peripheral Intervention Drug-Eluting Devices Customers
8 Peripheral Intervention Drug-Eluting Devices Market Dynamics
8.1 Peripheral Intervention Drug-Eluting Devices Industry Trends
8.2 Peripheral Intervention Drug-Eluting Devices Market Drivers
8.3 Peripheral Intervention Drug-Eluting Devices Market Challenges
8.4 Peripheral Intervention Drug-Eluting Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock